UK markets closed

Novartis AG (NVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
102.57-0.12 (-0.12%)
At close: 04:00PM EDT
102.93 +0.36 (+0.35%)
After hours: 05:16PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
47,733,000
46,660,000
43,461,000
43,974,000
49,898,000
Cost of revenue
12,577,000
12,472,000
11,582,000
11,735,000
15,121,000
Gross profit
35,156,000
34,188,000
31,879,000
32,239,000
34,777,000
Operating expenses
Research development
11,217,000
11,371,000
9,172,000
8,641,000
8,980,000
Selling general and administrative
12,466,000
12,517,000
12,193,000
12,827,000
14,197,000
Total operating expenses
24,632,000
24,419,000
23,933,000
22,183,000
24,625,000
Operating income or loss
10,524,000
9,769,000
7,946,000
10,056,000
10,152,000
Interest expense
876,000
855,000
800,000
787,000
869,000
Total other income/expenses net
-254,000
-227,000
-195,000
15,268,000
538,000
Income before tax
9,732,000
9,123,000
7,177,000
24,530,000
9,878,000
Income tax expense
622,000
551,000
1,128,000
1,625,000
1,807,000
Income from continuing operations
9,110,000
8,572,000
6,049,000
22,905,000
8,071,000
Net income
15,245,000
14,850,000
6,955,000
24,021,000
8,072,000
Net income available to common shareholders
15,245,000
14,850,000
6,955,000
24,021,000
8,072,000
Basic EPS
3.74
7.15
3.19
10.71
3.55
Diluted EPS
3.73
7.10
3.17
10.63
3.52
Basic average shares
2,097,750
2,076,794
2,181,180
2,242,601
2,277,000
Diluted average shares
2,113,000
2,092,000
2,197,000
2,260,000
2,296,000